HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Ocular Therapeutix (NASDAQ:OCUL) and maintained a $12 price target.
October 04, 2023 | 10:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ocular Therapeutix's stock may see positive movement as HC Wainwright & Co. has reiterated a 'Buy' rating and maintained a $12 price target.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, the reiteration of a 'Buy' rating and a maintained price target of $12 by HC Wainwright & Co. for Ocular Therapeutix indicates a positive outlook for the company's stock. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100